Incyte (NASDAQ:INCY) has received a mix of analyst ratings in the last quarter, with 3 bullish, 2 somewhat bullish, and 4 indifferent ratings. The average 12-month price target among 9 analysts is $78.67, which is a 12.59% decrease from the previous target of $90.00. The high estimate is $98.00 and the low is $63.00. Analysts rate stocks based on research and provide guidance on growth estimates, earnings, and revenue, but their ratings are opinions and should be considered as such.